Baidu
map

2024 国际共识标准:儿童脓毒症和脓毒性休克

2024-01-21 美国重症医学会 JAMA 发表于北京

美国重症医学会(SCCM)更新并评估了儿童脓毒症和脓毒性休克的标准。SCCM工作组建议,通过疑似感染儿童的Phoenix评分至少为2分来识别儿童脓毒症。

中文标题:

2024 国际共识标准:儿童脓毒症和脓毒性休克

英文标题:

International Consensus Criteria for Pediatric Sepsis and Septic Shock

发布机构:

美国重症医学会

发布日期:

2024-01-21

简要介绍:

脓毒症是全球范围内导致儿童死亡的主要原因,当前儿童脓毒症特定标准于2005年发布。2016年,Sepsis-3定义将脓毒症定义为由宿主对感染的反应失调而引起的致命性器官功能障碍,但不包括儿童。儿童脓毒症与成人脓毒症有重要区别,需要专门用于儿童的脓毒症的诊断标准。美国重症医学会(SCCM)更新并评估了儿童脓毒症和脓毒性休克的标准。SCCM工作组建议,通过疑似感染儿童的Phoenix评分至少为2分来识别儿童脓毒症。
 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2024 国际共识标准:儿童脓毒症和脓毒性休克.pdf)] GetToolGuiderByIdResponse(projectId=1, id=083c21c0035a960c, title=2024 国际共识标准:儿童脓毒症和脓毒性休克, enTitle=International Consensus Criteria for Pediatric Sepsis and Septic Shock, guiderFrom=JAMA, authorId=0, author=, summary=美国重症医学会(SCCM)更新并评估了儿童脓毒症和脓毒性休克的标准。SCCM工作组建议,通过疑似感染儿童的Phoenix评分至少为2分来识别儿童脓毒症。, cover=https://img.medsci.cn/Random/hospital-staff-at-work-PGMH47J.jpg, journalId=0, articlesId=null, associationId=385, associationName=美国重症医学会, associationIntro=《美国重症医学会》,是世界上最大的重症医学会,具有多学科,多专业的特点,拥有近100多个国家的16000名成员。sccm网站集临床,科研和教学于一体,跟踪报道重症医学的最新研究成果。学术会议发布,投稿和报名。, copyright=0, guiderPublishedTime=Sun Jan 21 00:00:00 CST 2024, originalUrl=, linkOutUrl=, content=<div class="guideDetailsCont flex-row-between-start" style="color: #333333;"> <div class="detailsContRight" style="color: #222222;">脓毒症是全球范围内导致儿童死亡的主要原因,当前儿童脓毒症特定标准于2005年发布。2016年,Sepsis-3定义将脓毒症定义为由宿主对感染的反应失调而引起的致命性器官功能障碍,但不包括儿童。儿童脓毒症与成人脓毒症有重要区别,需要专门用于儿童的脓毒症的诊断标准。美国重症医学会(SCCM)更新并评估了儿童脓毒症和脓毒性休克的标准。SCCM工作组建议,通过疑似感染儿童的Phoenix评分至少为2分来识别儿童脓毒症。</div> </div> <div class="detailsQRWrapper" style="color: #333333;"> <div id="app_detail" class="detailsQR" title="https://m.medlive.cn/guide/1/30890">&nbsp;</div> </div>, tagList=[TagDto(tagId=23032, tagName=脓毒性休克)], categoryList=[CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=38, categoryName=急重症, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=23032, articleKeyword=脓毒性休克, articleKeywordNum=6, guiderKeywordId=23032, guiderKeyword=脓毒性休克, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5483, appHits=94, showAppHits=0, pcHits=906, showPcHits=5383, likes=1, shares=16, comments=8, approvalStatus=1, publishedTime=Wed Jan 24 09:58:00 CST 2024, publishedTimeString=2024-01-21, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Tue Jan 23 16:42:00 CST 2024, updatedBy=8538692, updatedName=风湿免疫小助手, updatedTime=Tue Jan 23 22:47:10 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=北京, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2024 国际共识标准:儿童脓毒症和脓毒性休克.pdf)])
2024 国际共识标准:儿童脓毒症和脓毒性休克.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2200154, encodeId=5627220015485, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ce31650002, createdName=周红妹, createdTime=Wed Apr 24 17:33:07 CST 2024, time=2024-04-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190803, encodeId=475b219080331, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKvTVdw1ywH5ct8KBarLI4ZPHEgWJf9iaeMibKDqgQibMPD27BTlFcokmI7OtVwfP6rLU12J1ibibqiaeuA/132, createdBy=4ab42555642, createdName=吴⭐, createdTime=Sun Mar 03 19:41:45 CST 2024, time=2024-03-03, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2188400, encodeId=110721884004b, content=不错,非常需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4129176985, createdName=ms9000000858627372, createdTime=Tue Feb 20 21:49:36 CST 2024, time=2024-02-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2184511, encodeId=573a2184511da, content=更新换代很快 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211020/a19177b4a76046de8f46d357087a3921/6d4b4136268541f5a299525fe3ea791b.jpg, createdBy=49365641474, createdName=bibibinaomi, createdTime=Sun Jan 28 23:49:13 CST 2024, time=2024-01-28, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2184074, encodeId=f8b921840e474, content=好文献, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wrK88GbrwEH7IX8Qn6JNW417PI4aA1anS5cHVdzQnhC03fef3DsbXtkdx0a84diaAztGjAJlnOsiaqiaYDW2ibK8iaw/132, createdBy=ecbc5135505, createdName=13746658d9m, createdTime=Fri Jan 26 11:26:06 CST 2024, time=2024-01-26, status=1, ipAttribution=)]
    2024-04-24 周红妹 来自陕西省

    好东西

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2200154, encodeId=5627220015485, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ce31650002, createdName=周红妹, createdTime=Wed Apr 24 17:33:07 CST 2024, time=2024-04-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190803, encodeId=475b219080331, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKvTVdw1ywH5ct8KBarLI4ZPHEgWJf9iaeMibKDqgQibMPD27BTlFcokmI7OtVwfP6rLU12J1ibibqiaeuA/132, createdBy=4ab42555642, createdName=吴⭐, createdTime=Sun Mar 03 19:41:45 CST 2024, time=2024-03-03, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2188400, encodeId=110721884004b, content=不错,非常需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4129176985, createdName=ms9000000858627372, createdTime=Tue Feb 20 21:49:36 CST 2024, time=2024-02-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2184511, encodeId=573a2184511da, content=更新换代很快 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211020/a19177b4a76046de8f46d357087a3921/6d4b4136268541f5a299525fe3ea791b.jpg, createdBy=49365641474, createdName=bibibinaomi, createdTime=Sun Jan 28 23:49:13 CST 2024, time=2024-01-28, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2184074, encodeId=f8b921840e474, content=好文献, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wrK88GbrwEH7IX8Qn6JNW417PI4aA1anS5cHVdzQnhC03fef3DsbXtkdx0a84diaAztGjAJlnOsiaqiaYDW2ibK8iaw/132, createdBy=ecbc5135505, createdName=13746658d9m, createdTime=Fri Jan 26 11:26:06 CST 2024, time=2024-01-26, status=1, ipAttribution=)]
    2024-03-03 吴⭐ 来自陕西省

    非常好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2200154, encodeId=5627220015485, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ce31650002, createdName=周红妹, createdTime=Wed Apr 24 17:33:07 CST 2024, time=2024-04-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190803, encodeId=475b219080331, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKvTVdw1ywH5ct8KBarLI4ZPHEgWJf9iaeMibKDqgQibMPD27BTlFcokmI7OtVwfP6rLU12J1ibibqiaeuA/132, createdBy=4ab42555642, createdName=吴⭐, createdTime=Sun Mar 03 19:41:45 CST 2024, time=2024-03-03, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2188400, encodeId=110721884004b, content=不错,非常需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4129176985, createdName=ms9000000858627372, createdTime=Tue Feb 20 21:49:36 CST 2024, time=2024-02-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2184511, encodeId=573a2184511da, content=更新换代很快 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211020/a19177b4a76046de8f46d357087a3921/6d4b4136268541f5a299525fe3ea791b.jpg, createdBy=49365641474, createdName=bibibinaomi, createdTime=Sun Jan 28 23:49:13 CST 2024, time=2024-01-28, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2184074, encodeId=f8b921840e474, content=好文献, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wrK88GbrwEH7IX8Qn6JNW417PI4aA1anS5cHVdzQnhC03fef3DsbXtkdx0a84diaAztGjAJlnOsiaqiaYDW2ibK8iaw/132, createdBy=ecbc5135505, createdName=13746658d9m, createdTime=Fri Jan 26 11:26:06 CST 2024, time=2024-01-26, status=1, ipAttribution=)]
    2024-02-20 ms9000000858627372 来自山东省

    不错,非常需要

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2200154, encodeId=5627220015485, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ce31650002, createdName=周红妹, createdTime=Wed Apr 24 17:33:07 CST 2024, time=2024-04-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190803, encodeId=475b219080331, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKvTVdw1ywH5ct8KBarLI4ZPHEgWJf9iaeMibKDqgQibMPD27BTlFcokmI7OtVwfP6rLU12J1ibibqiaeuA/132, createdBy=4ab42555642, createdName=吴⭐, createdTime=Sun Mar 03 19:41:45 CST 2024, time=2024-03-03, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2188400, encodeId=110721884004b, content=不错,非常需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4129176985, createdName=ms9000000858627372, createdTime=Tue Feb 20 21:49:36 CST 2024, time=2024-02-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2184511, encodeId=573a2184511da, content=更新换代很快 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211020/a19177b4a76046de8f46d357087a3921/6d4b4136268541f5a299525fe3ea791b.jpg, createdBy=49365641474, createdName=bibibinaomi, createdTime=Sun Jan 28 23:49:13 CST 2024, time=2024-01-28, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2184074, encodeId=f8b921840e474, content=好文献, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wrK88GbrwEH7IX8Qn6JNW417PI4aA1anS5cHVdzQnhC03fef3DsbXtkdx0a84diaAztGjAJlnOsiaqiaYDW2ibK8iaw/132, createdBy=ecbc5135505, createdName=13746658d9m, createdTime=Fri Jan 26 11:26:06 CST 2024, time=2024-01-26, status=1, ipAttribution=)]
    2024-01-28 bibibinaomi 来自宁夏

    更新换代很快

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2200154, encodeId=5627220015485, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ce31650002, createdName=周红妹, createdTime=Wed Apr 24 17:33:07 CST 2024, time=2024-04-24, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190803, encodeId=475b219080331, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKvTVdw1ywH5ct8KBarLI4ZPHEgWJf9iaeMibKDqgQibMPD27BTlFcokmI7OtVwfP6rLU12J1ibibqiaeuA/132, createdBy=4ab42555642, createdName=吴⭐, createdTime=Sun Mar 03 19:41:45 CST 2024, time=2024-03-03, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2188400, encodeId=110721884004b, content=不错,非常需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4129176985, createdName=ms9000000858627372, createdTime=Tue Feb 20 21:49:36 CST 2024, time=2024-02-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2184511, encodeId=573a2184511da, content=更新换代很快 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211020/a19177b4a76046de8f46d357087a3921/6d4b4136268541f5a299525fe3ea791b.jpg, createdBy=49365641474, createdName=bibibinaomi, createdTime=Sun Jan 28 23:49:13 CST 2024, time=2024-01-28, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=2184074, encodeId=f8b921840e474, content=好文献, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wrK88GbrwEH7IX8Qn6JNW417PI4aA1anS5cHVdzQnhC03fef3DsbXtkdx0a84diaAztGjAJlnOsiaqiaYDW2ibK8iaw/132, createdBy=ecbc5135505, createdName=13746658d9m, createdTime=Fri Jan 26 11:26:06 CST 2024, time=2024-01-26, status=1, ipAttribution=)]
    2024-01-26 13746658d9m

    好文献

    0

拓展阅读

管理脓毒症和脓毒性休克患者内皮糖萼的有益方式:从拯救脓毒症运动指南的角度来看

在这篇综述中,我们探讨了与2021年生存脓毒症运动指南中推荐的治疗策略一致的治疗策略,特别强调了关于糖萼保护的证据。

脓毒性休克复苏时如何整合血流动力学指标?

在这篇综述中,提出了一种按照逻辑的阶梯式方法来整合相关的血流动力学参数,并为脓毒性休克提供最合适的治疗。

JAMA:低剂量皮质类固醇治疗成人重症肺部感染

皮质类固醇能够减机体对感染的免疫反应。对于患有COVID-19感染、严重社区获得性细菌性肺炎和中度至重度肺孢子菌肺炎(HIV患者)的患者,使用低剂量皮质类固醇治疗能够降低死亡率。

JAMA:延长性与间歇性输注β-内酰胺类抗生素治疗成人脓毒症或脓毒性休克的比较:系统性评价与Meta分析

脓毒症和脓毒性休克的危重症患者具有较高的死亡率,β-内酰胺类抗生素是一线治疗抗生素。本研究通过系统性评价与Meta分析,评估延长性输注β-内酰胺类抗生素与间歇性输注相比,是否能够降低死亡风险。

脓毒性休克血管加压药和糖皮质激素启动的时机

这篇评论围绕着血管加压药和糖皮质激素治疗的启动时间方面做了总结,描述了目前文献中的空白以及启动这些治疗时的考量因素。

Pediatr Crit Care Med:维生素 C、氢化可的松和硫胺素对脓毒性休克儿童复苏的可行性

在需要血管活性药物治疗脓毒性休克的儿童中,使用高剂量维生素C、氢化可的松和硫胺素的辅助治疗与标准治疗相比是可行的。

儿童脓毒性休克(感染性休克)诊治专家共识(2015版)

中华医学会儿科学分会 · 2016-04-21

日本脓毒症和脓毒性休克的管理指南

日本重症监护医学学会(JSICM,Japanese Society of Intensive Care Medicine) · 2018-02-02

中国脓毒症/脓毒性休克急诊治疗指南(2018)

中国医师协会急诊医师分会(CHINESE COLLEGE OF EMERGENCY PHYSICANS,CCEP) · 2018-09-20

《拯救脓毒症运动:脓毒症与脓毒性休克治疗国际指南(2021)》摘译与解读

安徽医科大学第二附属医院重症医学二科 · 2021-12-28

Baidu
map
Baidu
map
Baidu
map